TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...
SSHRC invests over $80k in new McGill research projects through the Partnership Engage Grants competition, two of which are directly related to COVID-19 research....
Martha Crago, Vice-Principal, Research and Innovation, announced today that Kristina Öhrvall has been promoted to Assistant Vice-Principal, Research Development, for a five-year term.
RSS